DCC Strategy 2012-2017

The Dundee Cancer Centre sets out:

1. To establish itself as a hub and build collaborations across all cancer-focused activities in the University of Dundee, NHS, CR-UK and other partner organisations in Tayside and beyond, both nationally and internationally.

  • The DCC will develop an inclusive and diverse suite of communication mechanisms and routes to support the Centre as the main hub for cancer activity in Dundee.Image previewTailored and targeted communications and stakeholder engagement will support other strategic DCC activity in building collaborations for advancing translational research and promoting clinical trials, enhancing and broadening research training and development as well as promoting wider public engagement.
  • The DCC will bring together a well informed and actively engaged community of cancer researchers, practitioners and supporters, which will provide a basis for exchange of ideas and building collaboration in priority areas.

2. To contribute to advancing translational research in Dundee and to promote national and international collaboration.

Image preview

  • The DCC will continue its focused support for translational cancer research, including patient-focused research, and will expand the scope and quality of the translational research in Dundee by providing annual pilot and pump priming support, improving availability of human tissue resources as well as providing opportunities for interaction and creative thinking. 
  • The DCC will strengthen and energise interactions between local cancer research and practice groups through a structured programme of thematic meetings, which will focus on developing new and novel collaborations in cancer priority areas across the University of Dundee and the NHS.

3. To support clinical trials and the activities of the joint Dundee-Edinburgh Experimental Cancer Medicine Centre (ECMC).

  • The DCC will continue to support clinical trials in Dundee, including those led by the Dundee-Edinburgh ECMC, through patient education and recruitment as part of its local engagement events.
  • The DCC will work to expand trial recruitment through a range of other routes, including electronic communications.

                                  Image previewImage previewImage preview

4. To enhance cancer research-related training and development in Dundee.

  • The DCC will continue its innovative and cross-disciplinary clinical and non-clinical PhD programme, covering the full spectrum of cancer research.
  • The DCC will develop a suite of complementary support opportunities for career development of cancer professionals, including undergraduate support.

5. To expand cancer-focused public engagement activities through science and health engagement programmes and work with local supporters, contributing to CR-UK, NHS and University strategies.

  • The DCC will expand its established programme of science and health engagement activities, focused on engaging the local community in Tayside and North East Fife and fostering a closer relationship with local supporters.
  • The DCC will embed awareness of public engagement and its importance within mainstream cancer training and career development.